ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (21)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bourke, S.C.
Right arrow Articles by Gibson, G.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bourke, S.C.
Right arrow Articles by Gibson, G.J.
Eur Respir J 2002; 19:1194-1201
Copyright ©ERS Journals Ltd 2002

Sleep and breathing in neuromuscular disease

S.C. Bourke and G.J. Gibson

University of Newcastle, Freeman Hospital, Newcastle upon Tyne, UK

CORRESPONDENCE: S.C. Bourke, Sir William Leech Centre for Lung Research, Freeman Hospital, Newcastle upon Tyne, NE7 7DN, UK. Fax: 44 1912132690. E-mail: sbourke@doctors.org.uk

Keywords: neuromuscular diseases, polysomnography, respiratory muscles, sleep

Received: August 10, 2001
Accepted January 8, 2002


   ABSTRACT
TOP
 ABSTRACT
Normal breathing and muscle...
 Neuromuscular disease
 Features specific to individual...
 Impact of noninvasive...
 Conclusions and practical...
 REFERENCES
 
Respiratory muscle weakness in neuromuscular disease causes significant morbidity and mortality. The published data on respiratory muscle activity and breathing during sleep in normal subjects, the impact of respiratory muscle weakness on sleep and breathing and the relations to daytime respiratory function in neuromuscular disease are reviewed here. In normal subjects during sleep upper airway resistance increases, chemosensitivity is reduced and the wakefulness drive to breathe is lost, resulting in a fall in ventilation. During rapid eye movement (REM) sleep, ribcage and accessory breathing muscles are suppressed, particularly during bursts of eye movements, and breathing is more irregular, rapid and shallow, with a further fall in ventilation.

In subjects with respiratory muscle weakness sleep is fragmented, with shorter total sleep time, frequent arousals, an increase in stage 1 sleep and a reduction in, or complete suppression of, REM sleep. Sleep­disordered breathing and nocturnal desaturation are common and most severe during REM sleep. Correlations between daytime respiratory function and nocturnal desaturation are moderate or weak, but daytime respiratory function has greater prognostic value than nocturnal measurements.

Noninvasive ventilation improves sleep quality and breathing in subjects with respiratory muscle weakness. However, the optimal criteria for initiation of ventilation and its role in rapidly progressive neuromuscular diseases are unclear.

Respiratory muscle weakness and sleep­disordered breathing are both common in neuromuscular diseases such as amyotrophic lateral sclerosis (ALS) 1–5, muscular dystrophies (e.g. Duchenne's muscular dystrophy (DMD) 6–10, and myotonic dystrophy (MD) 11–14, myopathies (e.g. nemaline myopathy 15), Guillian­Barré syndrome and myasthenia gravis 16–18. Respiratory muscle weakness, apnoeas and hypopnoeas, and abnormalities of breathing pattern and ventilatory drive may all contribute to nocturnal desaturation and sleep disruption, even before daytime ventilatory failure ensues. Patients with severe respiratory muscle weakness frequently complain of unrefreshing sleep, daytime sleepiness, impaired concentration, fatigue and lethargy due to nocturnal hypoventilation and sleep disruption 2–4, 7, 11, 19, 20. The risk of respiratory infections is increased by impairment of cough due to respiratory muscle or bulbar weakness, and death is frequently due to respiratory failure.

There is increasing evidence that noninvasive ventilation (NIV) improves survival 21–24 and quality of life 25 in neuromuscular disease complicated by respiratory muscle weakness. The prevalence of respiratory muscle weakness and sleep disruption in neuromuscular disease, the associated morbidity and mortality, and the potential efficacy of NIV emphasize the importance of understanding the adverse effects of weakness on sleep and nocturnal oxygenation, and of recognizing the resulting symptoms at an early stage. The role of overnight monitoring by either detailed polysomnography (PSG) or simple oximetry in clinical assessment of these patients is uncertain. In this review the normal effects of sleep on muscle activity and breathing are described, and then the evidence on disruption of sleep architecture, sleep­disordered breathing and nocturnal oxygenation in neuromuscular disease is reviewed. In particular, the relations between symptoms, daytime respiratory function and sleep­disordered breathing and sleep disruption are explored. Finally, the more specific findings in various diseases, and the impact of NIV on sleep and breathing in neuromuscular disease are described.


   Normal breathing and muscle activity during sleep
TOP
 ABSTRACT
 Normal breathing and muscle...
Neuromuscular disease
 Features specific to individual...
 Impact of noninvasive...
 Conclusions and practical...
 REFERENCES
 
Indices of ventilation during wakefulness and sleep are shown in figure 1Go 26.


Figure 1
View larger version (17K):
[in this window]
[in a new window]

  		a) Minute ventilation, b) tidal volume and c) respiratory rate during wakefulness and sleep in 10 normal adult subjects. Data are presented as mean±SEM. #: Ventilation lower during sleep compared to wake p<0.02; : p=0.01; +: tidal volume lower during sleep compared to wake p<0.05; **: p<0.01; §: respiratory rate higher in rapid eye movement (REM) compared to nonrapid eye movement sleep (NREM) or wake p<0.05. Data from GOULD et al. 26.

 
Nonrapid eye movement sleep
Electromyogram (EMG) studies have shown that at sleep onset (transition from alpha to theta electroencephalogram (EEG) activity) phasic diaphragmatic, intercostal and genioglossus activity fall and then rise again, while phasic and tonic activity of tensor palatini falls abruptly and remains low 27. Ventilation falls abruptly and is associated with a more rapid, shallow and regular breathing pattern 28, resulting in a rise in the partial pressure of carbon dioxide (PCO2) 28, 29. Ventilation shows only a slight further decline once sleep becomes established. Upper airway resistance (UAR) increases abruptly at sleep onset due to reduced activity of the pharyngeal dilator muscles but, in contrast to ventilation, there is a further progressive rise in UAR associated with increasing delta EEG activity in slow­wave sleep 30. The increase in phasic diaphragmatic and intercostal EMG activity in nonrapid eye movement (NREM) sleep (following the transient fall at sleep onset) reflects the rise in respiratory workload due to increased UAR. In subjects with a tracheostomy, the fall in ventilation and rise in end­tidal PCO2 during sleep are similar to normal subjects 31. This supports the hypothesis that the changes in ventilation during sleep result primarily from a reduction in ventilatory drive due to reduced chemosensitivity 29, 32 and loss of the wakefulness drive to breathe 33, rather than from the increase in UAR. The rise in genioglossus activity during NREM sleep, after the initial fall at sleep onset, may be important in maintaining airway patency 34.

Rapid eye movement sleep
During rapid eye movement (REM) sleep there is a marked generalized reduction in the tone of skeletal muscles, with the exception of the diaphragm and extra­ocular muscles 35. DOUGLAS et al. 28 reported a further fall in tidal volume (due to reduced ribcage contribution), minute ventilation and mean inspiratory flow (an index of ventilatory drive) from NREM to REM sleep. Two smaller studies reported only a trend for a fall in tidal volume, with no significant reduction in ventilation during REM compared to NREM. Although the ribcage contribution decreased, its effect was balanced by increased diaphragmatic activity 36 and respiratory rate 26.

REM sleep is not a homogeneous state, but comprises phasic REM associated with bursts of rapid eye movements, and tonic REM, between bursts of rapid eye movements. In comparison to tonic REM, phasic REM is associated with smaller tidal volume (due to less ribcage contribution), higher respiratory rate (due to a fall in expiratory time) 26, 36, 37 and lower minute ventilation. The breathing pattern is also more irregular 26, 36. The changes in tidal volume and respiratory rate are proportional to the intensity of the rapid eye movements 26, 36. Increasing phase shift between ribcage and abdominal movements accompanying the rapid eye movements has also been described, and may reflect relatively greater inhibition of the upper airway musculature leading to pharyngeal narrowing during eye movements 36.

In summary, REM sleep in healthy subjects is associated with a shift from predominantly ribcage to diaphragmatic breathing, and is heterogeneous; during bursts of rapid eye movements breathing is more irregular, rapid and shallow, with an overall fall in ventilation.


   Neuromuscular disease
TOP
 ABSTRACT
 Normal breathing and muscle...
 Neuromuscular disease
Features specific to individual...
 Impact of noninvasive...
 Conclusions and practical...
 REFERENCES
 
Muscle activity: adaptive mechanisms in respiratory muscle weakness
In some patients with respiratory muscle weakness, expiratory contraction of the abdominal muscles has been shown during wakefulness and NREM sleep (semirecumbent). Subsequent relaxation of the abdominal muscles at the onset of inspiration aids diaphragmatic descent and inspiration 38, 39.

Subjects with diaphragmatic weakness are particularly vulnerable to REM­related hypoventilation and desaturation. Unusual phasic inspiratory activity of sternocleidomastoid during REM has been reported in a proportion of subjects with severe diaphragmatic weakness due to ALS, which may be another acquired adaptive mechanism 1.

Sleep architecture
Reduced total sleep time 2, 3 and sleep efficiency 2 are well described in patients with respiratory muscle weakness. Marked sleep fragmentation is commonly seen in subjects with respiratory or sleep­related symptoms 3, 38 with frequent arousals 2, 3, 10, an increase in stage 1 sleep 3, 7 and reduction in REM sleep 1, 7, 38. Complete suppression of REM has been reported in association with severe diaphragmatic weakness 1, 38. As these subjects are most vulnerable to oxygen desaturation during REM sleep, its suppression may represent a compensatory mechanism. Studies in subjects with equivalent respiratory function have shown substantial variation in the degree of sleep disruption, which at least in part, appears to be related to the reported prevalence of symptoms 2, 3, 7–9, 40. In other populations sleep­related symptoms have a large impact on quality of life, shown, for example, by short form 36 (SF­36) health status scores in untreated obstructive sleep apnoea, and the improved scores on continuous positive airway pressure therapy. The quality of life of patients with ALS correlates with both daytime respiratory muscle function and polysomnographic indices 41.

Sleep breathing disorders in neuromuscular disease
The commonest form of sleep­disordered breathing in patients with respiratory muscle weakness is hypoventilation due to reduced tidal volume, particularly during REM sleep 3, 4. Similar REM­related hypoventilation has been described in several other situations (e.g. chronic obstructive pulmonary disease (COPD), cystic fibrosis and obesity hypoventilation syndrome) 42. The degree of overall hypoventilation is not consistently reported, perhaps reflecting the difficulty of quantitating hypoventilation compared to apnoeas and hypopnoeas. The distinction between hypoventilation and central hypopnoeas is arbitrary; the latter usually refer to discrete short periods when ventilation is reduced compared to a preceding reference period.

A high prevalence of sleep­disordered breathing has been reported in neuromuscular disease, irrespective of the primary disorder 2, 3, 7–10, 13, 40. The definition of apnoea is consistent in the vast majority of studies, but definitions of hypopnoea differ, depending whether oxygen desaturation (3 or 4%) and/or EEG arousal must also be present. The classification of events as "central" or "obstructive" using noninvasive monitoring is particularly difficult in neuromuscular disease. Obstructive apnoea may be misclassified as central when respiratory muscles are too weak to move the chest wall against a closed pharynx. SMITH et al. 9 showed phasic submental EMG activity during apparent central apnoeas in two subjects with DMD, and coined the term "pseudo­central apnoea". There are even greater pitfalls in the classification of hypopnoeas. Severe diaphragmatic weakness causes paradoxical movement of the chest and abdomen even without narrowing of the upper airway, which may cause misclassification of central hypopnoeas as obstructive. An increasing phase difference between chest and abdominal movements, stable or increasing submental EMG (particularly at the end of the event), phasic diaphragmatic EMG activity, and snoring provide strong supportive evidence for an obstructive aetiology 38.

The most frequently reported discrete sleep­breathing events in patients with respiratory muscle weakness are central hypopnoeas 3, 7, 9, 13, 16, 40, which are more frequent and prolonged in REM sleep 3, 7, 9, 13, 16, particularly phasic REM 38. During REM sleep, suppression of the intercostal and accessory respiratory muscles (including the abdominal muscles), combined with inadequate diaphragmatic recruitment, leads to hypoventilation. The degree of muscle suppression, and consequent reduction in ventilation, is proportional to the density of eye movements, and often meets the criteria for central hypopnoea during bursts of rapid eye movements. The degree of desaturation is related to the severity of diaphragmatic weakness 38, 39.

In some studies predominantly obstructive events have been reported, either in a substantial proportion of subjects 7, 10, 38 or overall 4, 8, 40. Obstructive events are more likely in subjects with a high body mass index (BMI) 40, who snore 7, 40, or have anatomical abnormalities such as macroglossia (e.g. in DMD) 7. Increased UAR during REM sleep may also contribute to obstructive apnoeas or hypopnoeas 8. Discrepancies in the proportion of obstructive events between studies of subjects with the same underlying condition and similar respiratory function are considerable. For example, FERGUSON et al. 3 reported purely central events in 17 subjects with bulbar ALS and mean vital capacity (VC) of 81%, while GAY et al. 4 reported predominantly obstructive events in 16 of 18 subjects with ALS and a mean VC of 82%. A similar discrepancy is seen in other neuromuscular diseases, such as DMD 7, 8 and MD 13, 14, and may reflect the inherent difficulty in classifying events using noninvasive monitoring. Notably, studies in which oesophageal pressure was recorded to accurately determine the nature of events have reported predominantly central events 13, 16.

The apnoea/hypopnoea index (AHI) has been shown to correlate to varying degrees with excessive daytime somnolence 2, 4, daytime arterial oxygen tension 7 and total lung capacity (TLC) 10 although not consistently. Overall however, the relation between the AHI and either sleep­related symptoms 13, 40 or respiratory muscle function 7, 10, 11, 13, 40 is poor.

Nocturnal oxygenation in neuromuscular disease, relation to daytime lung function and symptoms
In subjects with respiratory muscle weakness, nocturnal desaturation may occur due to any or all of the following: 1) overall hypoventilation, 2) periodic apnoeas and hypopnoeas, and probably 3) ventilation/perfusion mismatching due to increased atelectasis in the supine posture. The most profound desaturation occurs during REM 3, 8, 9, 39, 42, particularly phasic REM 38, usually related to central hypopnoeas/hypoventilation 3, 7, 9, 10, 13, 38, 40 (fig. 2Go). In patients with neuromuscular disease nocturnal oxygenation tends to be lower with increasing age and BMI 9, 39, 40.


Figure 2
View larger version (24K):
[in this window]
[in a new window]

  		Suppression of airflow, chest and abdominal movement during tonic and phasic rapid eye movement (REM). Phasic REM is identified by the burst of rapid eye movements, and indicated by a bar. The consequent reduction in the arterial oxygen saturation (Sa,O2) is indicated by the arrow.

 
Several studies have examined the relationship between daytime respiratory function and nocturnal oxygenation. As would be expected, indices of nocturnal saturation correlate with daytime arterial blood gases 7, 10, 39 and saturation 40. However, since nocturnal desaturation is likely to precede daytime respiratory failure more sensitive predictors of nocturnal desaturation have been sought. Less consistent and weaker relationships have been shown between nocturnal oxygen saturation and VC 10, 39, 40, fall in VC supine 38, 39, forced expiratory volume in one second (FEV1) 10, maximal expiratory pressure (PE,max) 9 and functional residual capacity 43 (table 1Go). However, it is important to note that indices of daytime lung function (VC and maximal inspiratory pressure (PI,max)) are better predictors of survival than overnight oxygen saturation 4, 44 and orthopnoea in the presence of substantial impairment of daytime respiratory muscle function may be a better predictor of benefit from NIV than nocturnal desaturation 45.


View this table:
[in this window]
[in a new window]

  		1 Relations between daytime pulmonary function tests and nocturnal oxygen saturation (Sa,O2) in neuromuscular disease.

 
Sleep­disordered breathing and nocturnal oxygen desaturation may be predicted by orthopnoea 2, waking with a sensation of breathlessness 16, excessive daytime somnolence 2, 4, 16 and difficulty sleeping 4. GAY et al. 4 found that excessive daytime somnolence was 100% sensitive (although only 57% specific) for predicting nocturnal desaturation. There is conflicting evidence on the relationship between symptoms and sleep­disordered breathing and nocturnal desaturation in subjects with DMD and equivalent daytime respiratory function 7, 9. Sleep symptoms may be under­reported by patients and, in very disabling conditions, are easily overlooked by clinicians 7. This emphasizes the importance of careful clinical evaluation for orthopnoea and sleep­related symptoms, which in the presence of moderate or severe respiratory muscle weakness may be an effective means of selecting patients for NIV.


   Features specific to individual disorders
TOP
 ABSTRACT
 Normal breathing and muscle...
 Neuromuscular disease
 Features specific to individual...
Impact of noninvasive...
 Conclusions and practical...
 REFERENCES
 
Isolated diaphragmatic paralysis
Subjects with isolated diaphragmatic paralysis are particularly prone to nocturnal desaturation during REM sleep 38, even with only unilateral involvement 46. Although few detailed polysomnographic studies have been performed in such patients, REM sleep 46 and slow­wave sleep (SWS) are likely to be reduced 38, 46. Daytime respiratory failure is unusual with isolated bilateral diaphragmatic paralysis unless there is coexisting intrinsic lung disease (e.g. COPD) or obesity 38, 46–49.

Amyotrophic lateral sclerosis
Most studies in ALS have been conducted on selected populations, e.g. with bulbar involvement 3, diaphragmatic involvement 1 or in the presence 2 or absence 50 of respiratory and/or sleep­related symptoms. In the largest unselected cross­sectional study, GAY et al. 4 reported a mean AHI of 11.3 events·h–1 in 21 subjects, of whom seven had an AHI >10. However, the principal cause of nocturnal desaturation was hypoventilation. Comparing the PSG results of the various studies, the frequency of sleep­disordered breathing is very variable (16.7–76.5%), and appears to reflect the prevalence of respiratory and sleep­related symptoms, and to a lesser extent, the impairment of daytime respiratory function in the populations studied 2–5, 50. A similar variation is seen with the degree of disruption of sleep architecture 1, 3–5. Diaphragmatic paresis or paralysis is associated with sleep disruption and a reduction in, or complete suppression of, REM 1. No significant relations between bulbar involvement and the severity of sleep­disordered breathing or the type of event (obstructive or central) have been reported 1–5, 50. Nocturnal desaturation and sleep disruption in ALS therefore appear to be due mainly to diaphragmatic weakness and hypoventilation, rather than to obstructive events due to bulbar weakness 1.

Duchenne muscular dystrophy
One study in 21 subjects with DMD using automated analysis reported apnoeas, which initially were mainly obstructive, but with disease progression the proportion of central apnoeas increased. The authors concluded that sleep­disordered breathing in DMD was initially obstructive in nature (which might have therapeutic implications), and suggested that the apparent increase in central events in serial studies may be due to misclassification ("pseudo­central" events) 8. Snoring and macroglossia are associated with obstructive apnoeas and hypopnoeas in DMD 7, but most studies have reported predominantly central events 7, 9, 10, 43. These data are supported by studies in other conditions in which oesophageal pressure was monitored to accurately stage events 13, 16.

In comparison to subjects with ALS and a similar impairment of daytime respiratory function, sleep architecture appears to be better preserved in DMD. In common with other neuromuscular conditions, the relation between daytime function and nocturnal oxygen desaturation or respiratory events is poor 7, 9, 10, but daytime function, specifically VC <1 L, is a more powerful prognostic predictor than any nocturnal index 44. Evidence on the relationships between sleep­disordered breathing and symptoms is contradictory 7–9, which may reflect how carefully symptoms were sought.

Myotonic dystrophy
Daytime somnolence, hypercapnia, sleep­disordered breathing and nocturnal desaturation are all common in MD 11–13. Furthermore, the AHI and degree of nocturnal desaturation are greater than in nonmyotonic neuromuscular disease with a similar degree of respiratory muscle weakness 12. Subjects with MD tend to be heavier than those with other forms of neuromuscular disease 12, and the degree of nocturnal desaturation is related to the BMI 11. In most patients with MD sleepiness is not clearly attributable to hypercapnia, sleep­disordered breathing or disturbance of sleep architecture 12, 51. MD is also associated with an irregular breathing pattern during wakefulness 52 and light sleep, which does not persist during SWS 51, 53, suggesting that the defect may be due to cortical, rather than medullary/central (chemosensitive drive) influences. Such irregularity of breathing pattern is not seen in nonmyotonic subjects with similar respiratory muscle weakness 53.

Myasthenia gravis
Several investigators have suggested that sleep­related symptoms in myasthesia gravis (MG) might reflect central nervous system involvement or occur as a side­effect of anticholinesterase therapy, yet there is little evidence to support this 54. Sleep­disordered breathing is common in MG associated with peripheral respiratory muscle weakness, particularly diaphragmatic weakness. In common with other conditions, sleep­disordered breathing and nocturnal desaturation are most pronounced during REM sleep 16, 18 and the majority of respiratory events are central. Older patients with a higher BMI, lower TLC and abnormal daytime arterial blood gases are most vulnerable 16. Sleep­disordered breathing and nocturnal desaturation may improve following treatment with thymectomy 17 or prednisolone 18.


   Impact of noninvasive ventilation on sleep in respiratory muscle weakness
TOP
 ABSTRACT
 Normal breathing and muscle...
 Neuromuscular disease
 Features specific to individual...
 Impact of noninvasive...
Conclusions and practical...
 REFERENCES
 
Negative­pressure ventilation
Negative­pressure ventilation was introduced in the 1950s to treat victims of the polio epidemics with respiratory failure. It has been shown to improve oxygenation, particularly during NREM sleep. Sleep architecture remains fragmented with frequent arousals 55. Episodes of severe desaturation still occur, particularly during REM sleep, associated with obstructive events. Negative­pressure ventilation contributes to upper airway obstruction both in subjects with neuromuscular disease 55–57 and in normal individuals 58. Both continuous positive airway pressure and tracheostomy reduce sleep­disordered breathing and improve sleep architecture in subjects receiving negative­pressure ventilation 56. While negative­pressure ventilation resembles the normal physiological thoracic and diaphragmatic inspiratory process more closely than positive­pressure ventilation, phasic inspiratory activity in the pharyngeal muscles supporting the upper airway is not stimulated, leading to frequent obstructive events and arousals.

Positive­pressure ventilation
In uncontrolled studies, positive­pressure ventilation improves nocturnal saturation, sleep­disordered breathing, sleep efficiency, and sleep architecture in neuromuscular disease 59, 60. The upper airway is supported, preventing obstructive apnoeas or hypopnoeas, and leading to a greater improvement in both oxygenation 55, 57 and sleep architecture than seen with negative­pressure ventilation 55. Daytime arterial blood gases improve with long­term nocturnal ventilation 59–62, and are associated with an increased ventilatory response to carbon dioxide 60.

No randomized­controlled trials of NIV initiated for hypercapnic respiratory failure have been performed in stable or slowly progressive neuromuscular disease, however NIV appears to improve survival compared to historical controls 21. In DMD specifically, NIV is associated with longer survival in subjects with symptomatic daytime hypercapnia when compared to those who declined NIV 63 or historical controls 22. Surprisingly, one randomized­controlled trial comparing earlier intervention (VC 20–50% predicted, normal daytime PCO2) with no NIV was associated with higher mortality in the treated group. The excess mortality was due to deaths from respiratory infections and retention of secretions. Although there was no difference in the frequency of respiratory infections in the two groups, fewer patients in the NIV group were treated with invasive ventilation (9 versus 26%), and most deaths occurred in subjects managed at home. The authors concluded that NIV did not increase the risk of respiratory infections, but false security may subsequently have led to suboptimal medical management 64. In contrast, successful treatment with NIV has been described in symptomatic patients with normal daytime carbon dioxide tension in arterial blood suffering from various neuromuscular conditions including muscular dystrophy 65.

In more rapidly progressive conditions such as ALS, NIV also appears to prolong survival 23, 24 and improve quality of life 25 although, at present, no randomized­controlled trials have been reported and the optimal timing of intervention is unclear. Although randomized­controlled trials data are lacking, in light of evidence of improvements in symptoms, daytime hypercapnia, nocturnal desaturation and 1-yr mortality, NIV is recommended in neuromuscular disease 66. Recent consensus guidelines suggest that it should be initiated for symptoms with either daytime hypercapnia or nocturnal desaturation (arterial oxygen saturation ≤88% for 5 min). In progressive neuromuscular disease NIV is also recommended if symptoms are present with PI,max<60 cmH2O or VC <50% pred 67. In the authors experience the emphasis on symptoms is particularly important and, at least in ALS, earlier intervention in the presence of orthopnoea with sleep­related symptoms and PI,max <60% pred even before development of daytime hypercapnia is associated with improved symptoms and quality of life 45.


   Conclusions and practical considerations
TOP
 ABSTRACT
 Normal breathing and muscle...
 Neuromuscular disease
 Features specific to individual...
 Impact of noninvasive...
 Conclusions and practical...
REFERENCES
 
Sleep­disordered breathing, sleep disruption and nocturnal desaturation are common in neuromuscular disease associated with respiratory muscle weakness. With severe weakness, diurnal respiratory failure often ensues. Symptoms related to sleep disruption and hypercapnia are a major cause of morbidity. Noninvasive positive­pressure ventilation improves sleep­disordered breathing, sleep architecture and more importantly, symptoms, quality of life and survival in slowly or nonprogressive neuromuscular disease, and probably also in more rapidly progressive diseases, such as ALS. The optimal time to initiate treatment and the roles of polysomnography or nocturnal oximetry in assessing patients have yet to be clearly defined.

Screening sleep studies have been recommended in patients with neuromuscular disease, often guided by serial daytime respiratory function tests (typically spirometry plus/minus blood gases) 9, 10, 39, 40. However in comparison to daytime lung function, nocturnal measurements, including oxygen saturation, are surprisingly weak predictors of survival 4, 44. In amyotrophic lateral sclerosis orthopnoea (due to respiratory muscle weakness) is a more sensitive predictor of benefit from noninvasive ventilation than either nocturnal desaturation or daytime hypercapnia and the apnoea/hypopnoea index is unhelpful 45. The studies available cast doubt on the need for routine polysomnography or nocturnal oximetry in assessing such patients for noninvasive ventilation, although polysomnography may identify the occasional patient with coexistent obstructive sleep apnoea. There is a need for further studies evaluating the optimal criteria for and timing of initiating noninvasive ventilation in patients with neuromuscular disease. Currently there is no evidence that sleep studies improve the selection of subjects for noninvasive ventilation over and above evaluation of symptoms and daytime respiratory function.


   REFERENCES
TOP
 ABSTRACT
 Normal breathing and muscle...
 Neuromuscular disease
 Features specific to individual...
 Impact of noninvasive...
 Conclusions and practical...
 REFERENCES
 

  1. Arnulf I, Similowski T, Salachas F, et al. Sleep disorders and diaphragmatic function in patients with amyotrophic lateral sclerosis. Am J Respir Crit Care Med 2000;161:849–856.[Abstract/Free Full Text]
  2. David WS, Bundlie SR, Mahdavi Z. Polysomnographic studies in amyotrophic lateral sclerosis. J Neurol Sci 1997;152:Suppl. 1, S29–S35.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  3. Ferguson KA, Strong MJ, Ahmad D, George CF. Sleep­disordered breathing in amyotrophic lateral sclerosis. Chest 1996;110:664–669.[Abstract/Free Full Text]
  4. Gay PC, Westbrook PR, Daube JR, Litchy WJ, Windebank AJ, Iverson R. Effects of alterations in pulmonary function and sleep variables on survival in patients with amyotrophic lateral sclerosis. Mayo Clin Proc 1991;66:686–694.[ISI][Medline] [Order article via Infotrieve]
  5. Minz M, Autret A, Laffont F, Beillevaire T, Cathala HP, Castaigne P. A study on sleep in amyotrophic lateral sclerosis. Biomedicine 1979;30:40–46.[ISI][Medline] [Order article via Infotrieve]
  6. Kirk VG, Flemons WW, Adams C, Rimmer KP, Montgomery MD. Sleep­disordered breathing in Duchenne muscular dystrophy: a preliminary study of the role of portable monitoring. Pediatr Pulmonol 2000;29:135–140.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  7. Barbe F, Quera­Salva MA, McCann C, et al. Sleep­related respiratory disturbances in patients with Duchenne muscular dystrophy. Eur Respir J 1994;7:1403–1408.[Abstract]
  8. Khan Y, Heckmatt JZ. Obstructive apnoeas in Duchenne muscular dystrophy. Thorax 1994;49:157–161.[Abstract]
  9. Smith PE, Calverley PM, Edwards RH. Hypoxemia during sleep in Duchenne muscular dystrophy. Am Rev Respir Dis 1988;137:884–888.[ISI][Medline] [Order article via Infotrieve]
  10. Hukins CA, Hillman DR. Daytime predictors of sleep hypoventilation in Duchenne muscular dystrophy. Am J Respir Crit Care Med 2000;161:166–170.[Abstract/Free Full Text]
  11. Finnimore AJ, Jackson RV, Morton A, Lynch E. Sleep hypoxia in myotonic dystrophy and its correlation with awake respiratory function. Thorax 1994;49:66–70.[Abstract]
  12. Gilmartin JJ, Cooper BG, Griffiths CJ, et al. Breathing during sleep in patients with myotonic dystrophy and non­myotonic respiratory muscle weakness. QJM 1991;78:21–31.[Abstract/Free Full Text]
  13. Cirignotta F, Mondini S, Zucconi M, et al. Sleep­related breathing impairment in myotonic dystrophy. J Neuroly 1987;235:80–85.[CrossRef]
  14. Guilleminault C, Cummiskey J, Motta J, Lynne­Davies P. Respiratory and hemodynamic study during wakefulness and sleep in myotonic dystrophy. Sleep 1978;1:19–31.[ISI][Medline] [Order article via Infotrieve]
  15. Sasaki M, Takeda M, Kobayashi K, Nonaka I. Respiratory failure in nemaline myopathy. Pediatr Neurol 1997;16:344–346.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  16. Quera­Salva MA, Guilleminault C, Chevret S, et al. Breathing disorders during sleep in myasthenia gravis. Ann Neurol 1992;31:86–92.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  17. Amino A, Shiozawa Z, Nagasaka T, et al. Sleep apnoea in well­controlled myasthenia gravis and the effect of thymectomy. J Neurol 1998;245:77–80.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  18. Papazian O. Rapid eye movement sleep alterations in myasthenia gravis. Neurology 1976;26:311–316.[Abstract/Free Full Text]
  19. Howard RS, Wiles CM, Loh L. Respiratory complications and their management in motor neuron disease. Brain 1989;112:1155–1170.[Abstract/Free Full Text]
  20. Howard RS, Wiles CM, Hirsch NP, Spencer GT. Respiratory involvement in primary muscle disorders: assessment and management. QJM 1993;86:175–189.[Abstract/Free Full Text]
  21. Simonds AK, Elliott MW. Outcome of domiciliary nasal intermittent positive pressure ventilation in restrictive and obstructive disorders. Thorax 1995;50:604–609.[Abstract]
  22. Simonds AK, Muntoni F, Heather S, Fielding S. Impact of nasal ventilation on survival in hypercapnic Duchenne muscular dystrophy. Thorax 1998;53:949–952.[Abstract/Free Full Text]
  23. Pinto AC, Evangelista T, Carvalho M, Alves MA, Sales Luis ML. Respiratory assistance with a non­invasive ventilator (Bipap) in MND/ALS patients: Survival rates in a controlled trial. J Neurol Sci 1995;129:Suppl., 19–26.
  24. Kleopa KA, Sherman M, Neal B, Romano GJ, Heiman­Patterson T. Bipap improves survival and rate of pulmonary function decline in patients with ALS. J Neurol Sci 1999;164:82–88.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  25. Lyall RA, Donaldson N, Fleming T, et al. A prospective study of quality of life in ALS patients treated with noninvasive ventilation. Neurology 2001;57:153–156.[Abstract/Free Full Text]
  26. Gould GA, Gugger M, Molloy J, Tsara VMSC, Douglas NJ. Breathing pattern and eye movement density during REM sleep in humans. Am Rev Respir Dis 1988;138:874–877.[ISI][Medline] [Order article via Infotrieve]
  27. Worsnop C, Kay A, Pierce R, Kim Y, Trinder J. Activity of respiratory pump and upper airway muscles during sleep onset. J Appl Physiol 1998;85:908–920.[Abstract/Free Full Text]
  28. Douglas NJ, White DP, Pickett CK, Weil JV, Zwillich CW. Respiration during sleep in normal man. Thorax 1982;37:840–844.[Abstract]
  29. Simon PM, Dempsey JA, Landry DM, Skatrud JB. Effect of sleep on respiratory muscle activity during mechanical ventilation. Am Rev Respir Dis 1993;147:32–37.[ISI][Medline] [Order article via Infotrieve]
  30. Kay A, Trinder J, Kim Y. Progressive changes in airway resistance during sleep. J Appl Physiol 1996;81:282–296.[Abstract/Free Full Text]
  31. Morrell MJ, Harty HR, Adams L, Guz A. Breathing during wakefulness and NREM sleep in humans without an upper airway. J Appl Physiol 1996;81:274–281.[Abstract/Free Full Text]
  32. Corfield DR, Roberts CA, Griffiths MJ, Adams L. Sleep­related changes in the human "neuromuscular" ventilatory response to hypoxia. Respir Physiol 1999;117:109–120.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  33. Morrell MJ, Shea SA, Adams L, Guz A. Effects of inspiratory support upon breathing in humans during wakefulness and sleep. Respir Physiol 1993;93:57–70.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  34. Tangel DJ, Mezzanotte WS, White DP. The influenze of sleep on the activity of tonic vs inspiratory phasic muscles in normal men. J Appl Physiol 1992;73:1058–1068.[Abstract/Free Full Text]
  35. Tabachnik E, Muller NL, Bryan AC, Levison H. Changes in ventilation and chest wall mechanics during sleep in normal adolescents. J Applied Physiol 1981;51:557–564.[Abstract/Free Full Text]
  36. Millman RP, Knight H, Kline LR, Shore ET, Chung DC, Pack AI. Changes in compartmental ventilation in association with rapid eye movements during REM sleep. J Appl Physiol 1988;65:196–202.[ISI]
  37. Schafer T, Schlafke ME. Respiratory changes associated with rapid eye movements in normo- and hypercapnia during sleep. J Appl Physiol 1998;85:2213–2219.[Abstract/Free Full Text]
  38. White JE, Drinnan MJ, Smithson AJ, Griffiths CJ, Gibson GJ. Respiratory muscle activity and oxygenation during sleep in patients with muscle weakness. Eur Respir J 1995;8:807–814.[Abstract]
  39. Bye PT, Ellis ER, Issa FG, Donnelly PM, Sullivan CE. Respiratory failure and sleep in neuromuscular disease. Thorax 1990;45:241–247.[Abstract]
  40. Labanowski M, Schmidt­Nowara W, Guilleminault C. Sleep and neuromuscular disease: frequency of sleep­disordered breathing in a neuromuscular disease clinic population. Neurology 1996;47:1173–1180.[Abstract/Free Full Text]
  41. Bourke SC, Shaw PS, Gibson GJ. Respiratory function vs sleep­disordered breathing as predictors of QOL in ALS. Neurology 2001;57:2040–2044.[Abstract/Free Full Text]
  42. Becker HF, Piper AJ, Flynn WE, et al. Breathing during sleep in patients with nocturnal desaturation. Am J Respir Crit Care Med 1999;159:112–118.[Abstract/Free Full Text]
  43. Manni R, Ottolini A, Cerveri I, et al. Breathing patterns and HbSaO2 changes during nocturnal sleep in patients with Duchenne muscular dystrophy. J Neurol 1989;236:391–394.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  44. Phillips MF, Smith PE, Carroll N, Edwards RH, Calverley PM. Nocturnal oxygenation and prognosis in Duchenne muscular dystrophy. Am J Respir Crit Care Med 1999;160:198–202.[Abstract/Free Full Text]
  45. Bourke SC, Shaw PJ, Bullock R, Gibson GJ. Criteria for initiating non­invasive ventilation in motor neurone disease. Am J Res Crit Care Med 2001;163:A153.
  46. Patakas D, Tsara V, Zoglopitis F, Daskalopoulou E, Argyropoulou P, Maniki E. Nocturnal hypoxia in unilateral diaphragmatic paralysis. Respiration 1991;58:95–99.[ISI][Medline] [Order article via Infotrieve]
  47. Mulvey DA, Aquilina RJ, Elliott MW, Moxham J, Green M. Diaphragmatic dysfunction in neuralgic amyotrophy: an electrophysiologic evaluation of 16 patients presenting with dyspnea. Am Rev Respir Dis 1993;147:66–71.[ISI][Medline] [Order article via Infotrieve]
  48. Skatrud J, Iber C, McHugh W, Rasmussen H, Nichols D. Determinants of hypoventilation during wakefulness and sleep in diaphragmatic paralysis. Am Rev Respir Dis 1980;121:587–593.[ISI][Medline] [Order article via Infotrieve]
  49. Camfferman F, Bogaard JM, van der Meche FG, Hilvering C. Idiopathic bilateral diaphragmatic paralysis. Eur J Respir Dis 1985;67:65–71.[ISI][Medline] [Order article via Infotrieve]
  50. Kimura K, Tachibana N, Kimura J, Shibasaki H. Sleep­disordered breathing at an early stage of amyotrophic lateral sclerosis. J Neurol Sci 1999;164:37–43.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  51. Ververs CC, Van der Meche FG, Verbraak AF, van der Sluys HC, Bogaard JM. Breathing pattern awake and asleep in myotonic dystrophy. Respiration 1996;63:1–7.[ISI][Medline] [Order article via Infotrieve]
  52. Serisier DE, Mastaglia FL, Gibson GJ. Respiratory muscle function and ventilatory control. I in patients with motor neurone disease. II in patients with myotonic dystrophy. QMJ 1982;51:205–226.
  53. Veale D, Cooper BG, Gilmartin JJ, Walls TJ, Griffith CJ, Gibson GJ. Breathing pattern awake and asleep in patients with myotonic dystrophy. Eur Respir J 1995;8:815–818.[Abstract]
  54. Keesey JC. Does myasthenia gravis affect the brain? J Neurol Sci 1999;170:77–89.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  55. Ellis ER, Bye PT, Bruderer JW, Sullivan CE. Treatment of respiratory failure during sleep in patients with neuromuscular disease. Positive­pressure ventilation through a nose mask. Am Rev Respir Dis 1987;135:148–152.[ISI][Medline] [Order article via Infotrieve]
  56. Hill NS, Redline S, Carskadon MA, Curran FJ, Millman RP. Sleep­disordered breathing in patients with Duchenne muscular dystrophy using negative pressure ventilators. Chest 1992;102:1656–1662.[Abstract/Free Full Text]
  57. Bach JR, Penek J. Obstructive sleep apnea complicating negative­pressure ventilatory support in patients with chronic paralytic/restrictive ventilatory dysfunction. Chest 1991;99:1386–1393.[Abstract/Free Full Text]
  58. Levy RD, Bradley TD, Newman SL, Macklem PT, Martin JG. Negative pressure ventilation. Effects on ventilation during sleep in normal subjects. Chest 1989;95:95–99.[Abstract/Free Full Text]
  59. Barbe F, Quera­Salva MA, de Lattre J, Gajdos P, Agusti AG. Long­term effects of nasal intermittent positive­pressure ventilation on pulmonary function and sleep architecture in patients with neuromuscular diseases. Chest 1996;110:1179–1183.[Abstract/Free Full Text]
  60. Annane D, Quera­Salva MA, Lofaso F, et al. Mechanisms underlying effects of nocturnal ventilation on daytime blood gases in neuromuscular diseases. Eur Respir J 1999;13:157–162.[Abstract]
  61. Bach JR, Alba AS. Management of chronic alveolar hypoventilation by nasal ventilation. Chest 1990;97:52–57.[Abstract/Free Full Text]
  62. Piper AJ, Sullivan CE. Effects of long­term nocturnal nasal ventilation on spontaneous breathing during sleep in neuromuscular and chest wall disorders. Eur Respir J 1996;9:1515–1522.[Abstract]
  63. Vianello A, Bevilacqua M, Salvador V, Cardaioli C, Vincenti E. Long­term nasal intermittent positive pressure ventilation in advanced Duchenne's muscular dystrophy. Chest 1994;105:445–448.[Abstract/Free Full Text]
  64. Raphael JC, Chevret S, Chastang C, Bouvet F. Randomised trial of preventive nasal ventilation in Duchenne muscular dystrophy. French Multicentre Cooperative Group on Home Mechanical Ventilation Assistance in Duchenne de Boulogne Muscular Dystrophy. Lancet 1994;343:1600–1604.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  65. Guilleminault C, Philip P, Robinson A. Sleep and neuromuscular disease: bilevel positive airway pressure by nasal mask as a treatment for sleep disordered breathing in patients with neuromuscular disease. J Neurol Neurosurg Psychiatry 1998;65:225–232.[Abstract/Free Full Text]
  66. Annane D, Chevrolet JC, Chevret S, Raphael JC. Nocturnal mechanical ventilation for chronic hypoventilation in patients with neuromuscular and chest wall disorders (Cochrane review) In: The Cochrane Library, Issue 4, 2001;. Oxford, Update Software.
  67. Anonymous. Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation ­ a consensus conference report. Chest 1999;116:521–354.[Free Full Text]



This article has been cited by other articles:


Home page
 Chronic Respiratory DiseaseHome page
M. Toussaint, M. Chatwin, and P. Soudon
Review Article: Mechanical ventilation in Duchenne patients with chronic respiratory insufficiency: clinical implications of 20 years published experience
Chronic Respiratory Disease, August 1, 2007; 4(3): 167 - 177.
[Abstract] [PDF]

Home page
 ChestHome page
M. Toussaint, M. Steens, and P. Soudon
Lung Function Accurately Predicts Hypercapnia in Patients With Duchenne Muscular Dystrophy
Chest, February 1, 2007; 131(2): 368 - 375.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
N. Chouri-Pontarollo, J.-C. Borel, R. Tamisier, B. Wuyam, P. Levy, and J.-L. Pepin
Impaired Objective Daytime Vigilance in Obesity-Hypoventilation Syndrome: Impact of Noninvasive Ventilation
Chest, January 1, 2007; 131(1): 148 - 155.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
A. Ahuja, D. Gothi, and J. M. Joshi
A 52-year-old man with daytime sleepiness, sialorrhea, and facial fasciculations.
Chest, July 1, 2006; 130(1): 287 - 290.
[Full Text] [PDF]

Home page
 ThoraxHome page
B Fauroux and F Lofaso
Non-invasive mechanical ventilation: when to start for what benefit?
Thorax, December 1, 2005; 60(12): 979 - 980.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
F. Laghi and M. J. Tobin
Disorders of the Respiratory Muscles
Am. J. Respir. Crit. Care Med., July 1, 2003; 168(1): 10 - 48.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
F. Lofaso and M.A. Quera-Salva
Polysomnography for the management of progressive neuromuscular disorders
Eur. Respir. J., June 1, 2002; 19(6): 989 - 990.
[Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (21)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bourke, S.C.
Right arrow Articles by Gibson, G.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bourke, S.C.
Right arrow Articles by Gibson, G.J.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS